Adaptimmune Therapeutics plc
ADAP
$0.3239
$0.01896.20%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/2/2025
-
MarketBeat
4/1/2025
-
Benzinga
3/30/2025
-
MarketBeat
3/29/2025
-
MarketBeat
3/27/2025
-
MarketBeat
3/26/2025
-
Insider Monkey
3/25/2025
-
MarketBeat
3/25/2025
-
TipRanks Financial Blog
3/24/2025
-
Ticker Report
3/22/2025
-
MarketBeat
3/22/2025
-
MarketBeat
3/22/2025
-
MarketBeat
3/21/2025
-
GuruFocus
3/21/2025
-
TipRanks Financial Blog
3/21/2025
-
GuruFocus
3/21/2025
-
MarketBeat
3/21/2025
-
GuruFocus
3/20/2025
-
Seeking Alpha: Transcripts
3/20/2025
-
SeekingAlpha
3/20/2025
-
FierceBiotech.com - Biotech
3/20/2025
-
GuruFocus
3/20/2025
-
Newsfile Corp. - News Releases
3/15/2025
-
Ticker Report
3/13/2025
-
MarketBeat
3/12/2025
-
Newsfile Corp. - News Releases
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 24, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
44 12 3543 0000
Address
60 Jubilee Avenue
Abingdon, OX14 4RX
Abingdon, OX14 4RX
Country
Year Founded
Business Description
Sector
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops...
more
